| OUE | 表記: | (4~{S})-4-azanyl-5-(carboxyamino)pentanoic acid | 組成式: | C6 H12 N2 O4 | SMILES: | N[CH](CCC(O)=O)CNC(O)=O | InChi: | InChI=1S/C6H12N2O4/c7-4(1-2-5(9)10)3-8-6(11)12/h4,8H,1-3,7H2,(H,9,10)(H,11,12)/t4-/m0/s1 | 定義日: | 2017-02-10 | 最終更新日: | 2024-09-27 | 公開日: | 2017-04-12 | 識別子(ID): | (4~{S})-4-azanyl-5-(carboxyamino)pentanoic acid |
|
| OUH | 表記: | [(2~{S})-2-azanyl-3-(1~{H}-imidazol-5-yl)propyl]carbamic acid | 組成式: | C7 H12 N4 O2 | SMILES: | N[CH](CNC(O)=O)Cc1[nH]cnc1 | InChi: | InChI=1S/C7H12N4O2/c8-5(2-10-7(12)13)1-6-3-9-4-11-6/h3-5,10H,1-2,8H2,(H,9,11)(H,12,13)/t5-/m0/s1 | 定義日: | 2017-02-10 | 最終更新日: | 2024-09-27 | 公開日: | 2017-04-12 | 識別子(ID): | [(2~{S})-2-azanyl-3-(1~{H}-imidazol-5-yl)propyl]carbamic acid |
|
| 4KZ | 表記: | N-[(1R)-1-(dihydroxyboranyl)-2-phenylethyl]-Nalpha-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide | 組成式: | C22 H23 B N4 O4 | SMILES: | c3(C(=O)NC(C(=O)NC(Cc1ccccc1)B(O)O)Cc2ccccc2)cnccn3 | InChi: | InChI=1S/C22H23BN4O4/c28-21(27-20(23(30)31)14-17-9-5-2-6-10-17)18(13-16-7-3-1-4-8-16)26-22(29)19-15-24-11-12-25-19/h1-12,15,18,20,30-31H,13-14H2,(H,26,29)(H,27,28)/t18-,20-/m0/s1 | 定義日: | 2015-04-02 | 最終更新日: | 2024-09-27 | 公開日: | 2016-03-16 | 識別子(ID): | N-[(1R)-1-(dihydroxyboranyl)-2-phenylethyl]-Nalpha-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide |
|
| OUI | 表記: | [(2~{S},3~{S})-2-azanyl-3-methyl-pentyl]carbamic acid | 組成式: | C7 H16 N2 O2 | SMILES: | CC[CH](C)[CH](N)CNC(O)=O | InChi: | InChI=1S/C7H16N2O2/c1-3-5(2)6(8)4-9-7(10)11/h5-6,9H,3-4,8H2,1-2H3,(H,10,11)/t5-,6+/m0/s1 | 定義日: | 2017-02-10 | 最終更新日: | 2024-09-27 | 公開日: | 2017-04-12 | 識別子(ID): | [(2~{S},3~{S})-2-azanyl-3-methyl-pentyl]carbamic acid |
|
| OUK | 表記: | [(5~{S})-5-azanyl-6-(carboxyamino)hexyl]azanium | 組成式: | C7 H18 N3 O2 | SMILES: | N[CH](CCCC[NH3+])CNC(O)=O | InChi: | InChI=1S/C7H17N3O2/c8-4-2-1-3-6(9)5-10-7(11)12/h6,10H,1-5,8-9H2,(H,11,12)/p+1/t6-/m0/s1 | 定義日: | 2017-02-10 | 最終更新日: | 2024-09-27 | 公開日: | 2017-04-12 | 識別子(ID): | [(5~{S})-5-azanyl-6-(carboxyamino)hexyl]azanium |
|
| OUL | 表記: | 4-(4-aminocarbonylphenoxy)benzamide | 組成式: | C14 H12 N2 O3 | SMILES: | NC(=O)c1ccc(Oc2ccc(cc2)C(N)=O)cc1 | InChi: | InChI=1S/C14H12N2O3/c15-13(17)9-1-5-11(6-2-9)19-12-7-3-10(4-8-12)14(16)18/h1-8H,(H2,15,17)(H2,16,18) | 別名: | OUL35 | 定義日: | 2017-09-25 | 最終更新日: | 2024-09-27 | 公開日: | 2018-07-25 | 識別子(ID): | 4-(4-aminocarbonylphenoxy)benzamide |
|
| 4L8 | 表記: | (2R)-2-(aminomethyl)-4-methylpentanoic acid | 組成式: | C7 H15 N O2 | SMILES: | C(C(CN)C(O)=O)C(C)C | InChi: | InChI=1S/C7H15NO2/c1-5(2)3-6(4-8)7(9)10/h5-6H,3-4,8H2,1-2H3,(H,9,10)/t6-/m1/s1 | 定義日: | 2015-04-08 | 最終更新日: | 2024-09-27 | 公開日: | 2015-08-26 | 識別子(ID): | (2R)-2-(aminomethyl)-4-methylpentanoic acid |
|
| OUU | 表記: | (1~{S},2~{R},3~{R},4~{S},6~{S})-2-(2-acetamidoethoxy)-3,4,6-tris(oxidanyl)cyclohexane-1-carboxylic acid | 組成式: | C11 H19 N O7 | SMILES: | CC(=O)NCCO[CH]1[CH](O)[CH](O)C[CH](O)[CH]1C(O)=O | InChi: | InChI=1S/C11H19NO7/c1-5(13)12-2-3-19-10-8(11(17)18)6(14)4-7(15)9(10)16/h6-10,14-16H,2-4H2,1H3,(H,12,13)(H,17,18)/t6-,7-,8-,9+,10+/m0/s1 | 定義日: | 2022-09-21 | 最終更新日: | 2024-09-27 | 公開日: | 2022-12-28 | 識別子(ID): | (1~{S},2~{R},3~{R},4~{S},6~{S})-2-(2-acetamidoethoxy)-3,4,6-tris(oxidanyl)cyclohexane-1-carboxylic acid |
|
| 4LF | 表記: | N-[2-[2,5-bis(oxidanylidene)pyrrol-1-yl]ethyl]-2,3-bis(oxidanyl)benzamide | 組成式: | C13 H12 N2 O5 | SMILES: | Oc1cccc(C(=O)NCCN2C(=O)C=CC2=O)c1O | InChi: | InChI=1S/C13H12N2O5/c16-9-3-1-2-8(12(9)19)13(20)14-6-7-15-10(17)4-5-11(15)18/h1-5,16,19H,6-7H2,(H,14,20) | 定義日: | 2015-08-06 | 最終更新日: | 2024-09-27 | 公開日: | 2015-11-18 | 識別子(ID): | N-[2-[2,5-bis(oxidanylidene)pyrrol-1-yl]ethyl]-2,3-bis(oxidanyl)benzamide |
|
| 4LH | 表記: | N-(3-{[(5-chloro-2-{[2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)amino]methyl}phenyl)prop-2-enamide | 組成式: | C26 H30 Cl N7 O2 | SMILES: | c3(Nc1c(OC)cc(cc1)N2CCN(C)CC2)ncc(c(n3)NCc4cc(NC(/C=C)=O)ccc4)Cl | InChi: | InChI=1S/C26H30ClN7O2/c1-4-24(35)30-19-7-5-6-18(14-19)16-28-25-21(27)17-29-26(32-25)31-22-9-8-20(15-23(22)36-3)34-12-10-33(2)11-13-34/h4-9,14-15,17H,1,10-13,16H2,2-3H3,(H,30,35)(H2,28,29,31,32) | 定義日: | 2015-04-10 | 最終更新日: | 2024-09-27 | 公開日: | 2016-02-10 | 識別子(ID): | N-(3-{[(5-chloro-2-{[2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)amino]methyl}phenyl)prop-2-enamide |
|
| OV2 | 表記: | N-hexanoyl-L-valyl-N~1~-[(2R,3S,4S)-1,3-dihydroxy-2,6-dimethylheptan-4-yl]-N~5~,N~5~-dimethyl-L-glutamamide | 組成式: | C27 H52 N4 O6 | SMILES: | O=C(NC(C(O)C(CO)C)CC(C)C)C(NC(=O)C(NC(=O)CCCCC)C(C)C)CCC(=O)N(C)C | InChi: | InChI=1S/C27H52N4O6/c1-9-10-11-12-22(33)30-24(18(4)5)27(37)28-20(13-14-23(34)31(7)8)26(36)29-21(15-17(2)3)25(35)19(6)16-32/h17-21,24-25,32,35H,9-16H2,1-8H3,(H,28,37)(H,29,36)(H,30,33)/t19-,20+,21+,24+,25+/m1/s1 | 別名: | Carmaphycin A analogue, bound from | 定義日: | 2012-12-10 | 最終更新日: | 2024-09-27 | 公開日: | 2014-01-29 | 識別子(ID): | N-hexanoyl-L-valyl-N~1~-[(2R,3S,4S)-1,3-dihydroxy-2,6-dimethylheptan-4-yl]-N~5~,N~5~-dimethyl-L-glutamamide |
|
| OV3 | 表記: | (1~{S},2~{R},3~{R},4~{S},6~{S})-3,4,6-tris(oxidanyl)-2-[2-[2,2,2-tris(fluoranyl)ethanoylamino]ethoxy]cyclohexane-1-carboxylic acid | 組成式: | C11 H16 F3 N O7 | SMILES: | O[CH]1C[CH](O)[CH]([CH](OCCNC(=O)C(F)(F)F)[CH]1O)C(O)=O | InChi: | InChI=1S/C11H16F3NO7/c12-11(13,14)10(21)15-1-2-22-8-6(9(19)20)4(16)3-5(17)7(8)18/h4-8,16-18H,1-3H2,(H,15,21)(H,19,20)/t4-,5-,6-,7+,8+/m0/s1 | 定義日: | 2022-09-21 | 最終更新日: | 2024-09-27 | 公開日: | 2022-12-28 | 識別子(ID): | (1~{S},2~{R},3~{R},4~{S},6~{S})-3,4,6-tris(oxidanyl)-2-[2-[2,2,2-tris(fluoranyl)ethanoylamino]ethoxy]cyclohexane-1-carboxylic acid |
|
| 4LJ | 表記: | 1.7.6 3-bromanylpropan-1-amine | 組成式: | C3 H8 Br N | SMILES: | NCCCBr | InChi: | InChI=1S/C3H8BrN/c4-2-1-3-5/h1-3,5H2 | 定義日: | 2015-04-10 | 最終更新日: | 2024-09-27 | 公開日: | 2015-09-16 | 識別子(ID): | 3-bromanylpropan-1-amine |
|
| OV7 | 表記: | (2R)-amino[(carboxymethyl)sulfanyl]acetic acid | 組成式: | C4 H7 N O4 S | SMILES: | NC(C(O)=O)SCC(O)=O | InChi: | InChI=1S/C4H7NO4S/c5-3(4(8)9)10-1-2(6)7/h3H,1,5H2,(H,6,7)(H,8,9)/t3-/m1/s1 | 定義日: | 2019-07-08 | 最終更新日: | 2024-09-27 | 公開日: | 2019-08-07 | 識別子(ID): | (2R)-amino[(carboxymethyl)sulfanyl]acetic acid |
|
| 4LT | 表記: | (2R)-2-fluoropropanoic acid | 組成式: | C3 H5 F O2 | SMILES: | C(C(C)F)(O)=O | InChi: | InChI=1S/C3H5FO2/c1-2(4)3(5)6/h2H,1H3,(H,5,6)/t2-/m1/s1 | 定義日: | 2015-12-29 | 最終更新日: | 2024-09-27 | 公開日: | 2016-11-02 | 識別子(ID): | (2R)-2-fluoropropanoic acid |
|
| 4LZ | 表記: | O-[2-(triaza-1,2-dien-2-ium-1-yl)ethyl]-L-tyrosine | 組成式: | C11 H15 N4 O3 | SMILES: | C(C(N)Cc1ccc(OCCN=[N+]=N)cc1)(=O)O | InChi: | InChI=1S/C11H14N4O3/c12-10(11(16)17)7-8-1-3-9(4-2-8)18-6-5-14-15-13/h1-4,10,13H,5-7,12H2/p+1/t10-/m0/s1 | 定義日: | 2015-04-14 | 最終更新日: | 2024-09-27 | 公開日: | 2015-05-06 | 識別子(ID): | O-[2-(triaza-1,2-dien-2-ium-1-yl)ethyl]-L-tyrosine |
|
| 4M5 | 表記: | (4~{Z},7~{Z},10~{Z},13~{Z},19~{Z})-17-oxidanylidenedocosa-4,7,10,13,19-pentaenoic acid | 組成式: | C22 H32 O3 | SMILES: | CCC=CCC(=O)CCC=CCC=CCC=CCC=CCCC(O)=O | InChi: | InChI=1S/C22H32O3/c1-2-3-15-18-21(23)19-16-13-11-9-7-5-4-6-8-10-12-14-17-20-22(24)25/h3,5-8,11-15H,2,4,9-10,16-20H2,1H3,(H,24,25)/b7-5-,8-6-,13-11-,14-12-,15-3- | 定義日: | 2015-10-27 | 最終更新日: | 2024-09-27 | 公開日: | 2016-07-06 | 識別子(ID): | (4~{Z},7~{Z},10~{Z},13~{Z},19~{Z})-17-oxidanylidenedocosa-4,7,10,13,19-pentaenoic acid |
|
| 4M8 | 表記: | (2S)-2-amino-4-[(S)-hydroxy(methoxy)phosphoryl]butanoic acid | 組成式: | C5 H12 N O5 P | SMILES: | O=P(CCC(C(O)=O)N)(O)OC | InChi: | InChI=1S/C5H12NO5P/c1-11-12(9,10)3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)(H,9,10)/t4-/m0/s1 | 定義日: | 2015-04-15 | 最終更新日: | 2024-09-27 | 公開日: | 2015-06-03 | 識別子(ID): | (2S)-2-amino-4-[(S)-hydroxy(methoxy)phosphoryl]butanoic acid |
|
| 4M9 | 表記: | (4Z)-4-imino-4-[(4Z)-4-(1H-indol-3-ylmethylidene)-5-oxo-1-(2-oxoethyl)-4,5-dihydro-1H-imidazol-2-yl]butanamide | 組成式: | C18 H17 N5 O4 | SMILES: | O=C1/C(N=C(N1CC=O)/C(CCC(=O)N)=N)=C/c2cnc3ccccc23 | InChi: | InChI=1S/C18H17N5O4/c19-12(5-6-15(20)24)17-22-14(18(27)23(17)9-16(25)26)7-10-8-21-13-4-2-1-3-11(10)13/h1-4,7-8,19,21H,5-6,9H2,(H2,20,24)(H,25,26)/b14-7-,19-12+ | 別名: | CHROMOPHORE (GLN-TRP-GLY) | 定義日: | 2015-04-15 | 最終更新日: | 2024-09-27 | 公開日: | 2015-12-23 | 識別子(ID): | (4Z)-4-imino-4-[(4Z)-4-(1H-indol-3-ylmethylidene)-5-oxo-1-(2-oxoethyl)-4,5-dihydro-1H-imidazol-2-yl]butanamide |
|
| OVV | 表記: | 3-methylbenzoic acid | 組成式: | C8 H8 O2 | SMILES: | Cc1cccc(c1)C(O)=O | InChi: | InChI=1S/C8H8O2/c1-6-3-2-4-7(5-6)8(9)10/h2-5H,1H3,(H,9,10) | 定義日: | 2019-07-10 | 最終更新日: | 2024-09-27 | 公開日: | 2019-11-27 | 識別子(ID): | 3-methylbenzoic acid |
|
| OW1 | 表記: | Nirmatrelvir (reacted form) | 組成式: | C24 H35 F3 N4 O4 | SMILES: | CC(C)(C)[CH](NC(=O)C(F)(F)F)C(=O)N1C[CH]2[CH]([CH]1C(=O)N[CH](C[CH]3CCNC3=O)C=C)C2(C)C | InChi: | InChI=1S/C24H35F3N4O4/c1-7-13(10-12-8-9-28-18(12)32)29-19(33)16-15-14(23(15,5)6)11-31(16)20(34)17(22(2,3)4)30-21(35)24(25,26)27/h7,12-17H,1,8-11H2,2-6H3,(H,28,32)(H,29,33)(H,30,35)/t12-,13+,14-,15-,16-,17+/m0/s1 | 別名: | (1~{R},2~{S},5~{S})-3-[(2~{S})-3,3-dimethyl-2-[2,2,2-tris(fluoranyl)ethanoylamino]butanoyl]-6,6-dimethyl-~{N}-[(2~{S})-1-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]but-3-en-2-yl]-3-azabicyclo[3.1.0]hexane-2-carboxamide | 定義日: | 2022-09-22 | 最終更新日: | 2024-09-27 | 公開日: | 2023-02-22 | 識別子(ID): | (1~{R},2~{S},5~{S})-3-[(2~{S})-3,3-dimethyl-2-[2,2,2-tris(fluoranyl)ethanoylamino]butanoyl]-6,6-dimethyl-~{N}-[(2~{S})-1-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]but-3-en-2-yl]-3-azabicyclo[3.1.0]hexane-2-carboxamide |
|
| 4MM | 表記: | N,N,N-trimethylmethionine | 組成式: | C8 H18 N O2 S | SMILES: | CSCCC([N+](C)(C)C)C(=O)O | InChi: | InChI=1S/C8H17NO2S/c1-9(2,3)7(8(10)11)5-6-12-4/h7H,5-6H2,1-4H3/p+1/t7-/m0/s1 | 別名: | (1S)-1-carboxy-N,N,N-trimethyl-3-(methylsulfanyl)propan-1-aminium | 定義日: | 2011-06-04 | 最終更新日: | 2024-09-27 | 識別子(ID): | (1S)-1-carboxy-N,N,N-trimethyl-3-(methylsulfanyl)propan-1-aminium |
|
| OW9 | 表記: | 1-(3-methylphenyl)carbonylpyrrolo[3,2-c]pyridine-3-carbonitrile | 組成式: | C16 H11 N3 O | SMILES: | Cc1cccc(c1)C(=O)n2cc(C#N)c3cnccc23 | InChi: | InChI=1S/C16H11N3O/c1-11-3-2-4-12(7-11)16(20)19-10-13(8-17)14-9-18-6-5-15(14)19/h2-7,9-10H,1H3 | 定義日: | 2022-09-22 | 最終更新日: | 2024-09-27 | 公開日: | 2023-09-20 | 識別子(ID): | 1-(3-methylphenyl)carbonylpyrrolo[3,2-c]pyridine-3-carbonitrile |
|
| OWF | 表記: | (3S)-3-hydroxy-D-asparagine | 組成式: | C4 H8 N2 O4 | SMILES: | NC(=O)C(O)C(N)C(O)=O | InChi: | InChI=1S/C4H8N2O4/c5-1(4(9)10)2(7)3(6)8/h1-2,7H,5H2,(H2,6,8)(H,9,10)/t1-,2+/m1/s1 | 定義日: | 2022-05-18 | 最終更新日: | 2024-09-27 | 公開日: | 2023-01-11 | 識別子(ID): | (3S)-3-hydroxy-D-asparagine |
|
| 4MT | 表記: | N-[2-(4-hydroxyphenyl)ethyl]thioformamide | 組成式: | C9 H11 N O S | SMILES: | S=CNCCc1ccc(O)cc1 | InChi: | InChI=1S/C9H11NOS/c11-9-3-1-8(2-4-9)5-6-10-7-12/h1-4,7,11H,5-6H2,(H,10,12) | 別名: | N-(4-hydroxyphenethyl)methanethioamide | 定義日: | 2014-02-17 | 最終更新日: | 2024-09-27 | 公開日: | 2014-03-12 | 識別子(ID): | N-[2-(4-hydroxyphenyl)ethyl]thioformamide |
|